Structure of EthR in a ligand bound conformation reveals therapeutic perspectives against tuberculosis

被引:97
作者
Frénois, F
Engohang-Ndong, J
Locht, C
Baulard, AR
Villeret, V
机构
[1] Inst Pasteur, INSERM, U629, Inst Biol Lille, F-59019 Lille, France
[2] Inst Pasteur, CNRS, UMR8525, Inst Biol Lille, F-59019 Lille, France
关键词
D O I
10.1016/j.molcel.2004.09.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mycobacterium tuberculosis EthR is a repressor of ethA, a gene encoding a mono-oxygenase required for the activation of the prodrug ethionamide. Here we describe the X-ray crystal structure of EthR, a homodimer with an entirely helical structure showing similarities to TetR family members. Each monomer contained a fortuitous ligand identified as hexadecyl octanoate. The crystal structure of EthR purified in M. smegmatis revealed the presence of a comparable ligand. The binding of hexadecyl octanoate to EthR induces a conformational state incompatible with repressor function, which should lead to ethA derepression and consequently to an increased sensitivity to ethionamide and other thioamides. A related, more hydrophilic ketone was found to exhibit synergistic antimycobacterial effects when tested together with ethionamide, indicating that this strategy may help reduce the dosage of potent antibacterial compounds that otherwise are too toxic to be used as first-line drugs.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 36 条
[1]   Residues important for the function of a multihelical DNA binding domain in the new transcription factor family of Cam and Tet repressors [J].
Aramaki, H ;
Yagi, N ;
Suzuki, M .
PROTEIN ENGINEERING, 1995, 8 (12) :1259-1266
[2]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[3]  
Baulard AR, 2000, J BIOL CHEM, V275, P28326
[4]  
BLANC L, 2003, WHOTB2003313
[5]   Generation, representation and flow of phase information in structure determination:: recent developments in and around SHARP 2.0 [J].
Bricogne, G ;
Vonrhein, C ;
Flensburg, C ;
Schiltz, M ;
Paciorek, W .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2003, 59 :2023-2030
[6]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[7]   Current medical treatment for tuberculosis [J].
Chan, ED ;
Iseman, MD .
BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7375) :1282-1286
[8]   The growing burden of tuberculosis - Global trends and interactions with the HIV epidemic [J].
Corbett, EL ;
Watt, CJ ;
Walker, N ;
Maher, D ;
Williams, BG ;
Raviglione, MC ;
Dye, C .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (09) :1009-1021
[9]   Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis [J].
DeBarber, AE ;
Mdluli, K ;
Bosman, M ;
Bekker, LG ;
Barry, CE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9677-9682
[10]   Preparation of selenomethionyl proteins for phase determination [J].
Doublie, S .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :523-530